FR2227857A1 - - Google Patents

Info

Publication number
FR2227857A1
FR2227857A1 FR7415032A FR7415032A FR2227857A1 FR 2227857 A1 FR2227857 A1 FR 2227857A1 FR 7415032 A FR7415032 A FR 7415032A FR 7415032 A FR7415032 A FR 7415032A FR 2227857 A1 FR2227857 A1 FR 2227857A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7415032A
Other versions
FR2227857B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of FR2227857A1 publication Critical patent/FR2227857A1/fr
Application granted granted Critical
Publication of FR2227857B1 publication Critical patent/FR2227857B1/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7415032A 1973-05-03 1974-04-30 Expired FR2227857B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00356987A US3855203A (en) 1973-05-03 1973-05-03 4{41 -o-sulfonyl erythromycin-9-o-oxime derivatives

Publications (2)

Publication Number Publication Date
FR2227857A1 true FR2227857A1 (fr) 1974-11-29
FR2227857B1 FR2227857B1 (fr) 1977-11-04

Family

ID=23403817

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7415032A Expired FR2227857B1 (fr) 1973-05-03 1974-04-30

Country Status (6)

Country Link
US (1) US3855203A (fr)
JP (1) JPS5727117B2 (fr)
CA (1) CA1022169A (fr)
FR (1) FR2227857B1 (fr)
GB (1) GB1455396A (fr)
ZA (1) ZA742273B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4136253A (en) * 1977-05-11 1979-01-23 Pfizer Inc. Semi-synthetic 4"-sulfonylamino-oleandomycin derivatives
GB2010242B (en) * 1977-11-14 1982-06-16 Gen Electric Alumina calcia baria sealing composition and article of manufacture
US5932710A (en) 1997-12-01 1999-08-03 Abbott Laboratories Process for preparing 6-O-alkyl-9-oxime erythromycin B

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU31319B (en) * 1967-08-03 1973-04-30 Pliva Pharm & Chem Works Postupak za dobijanje acil derivata eritromicin oksima
US3681326A (en) * 1971-01-11 1972-08-01 Abbott Lab 9-substituted erythromycin a and b oximes
US3736313A (en) * 1971-02-26 1973-05-29 Abbott Lab Erythromycin derivatives

Also Published As

Publication number Publication date
DE2421269A1 (de) 1974-11-21
DE2421269B2 (de) 1976-07-22
JPS5727117B2 (fr) 1982-06-08
ZA742273B (en) 1975-03-26
FR2227857B1 (fr) 1977-11-04
US3855203A (en) 1974-12-17
CA1022169A (en) 1977-12-06
JPS5018486A (fr) 1975-02-26
GB1455396A (en) 1976-11-10
AU6790674A (en) 1975-10-16

Similar Documents

Publication Publication Date Title
AR201758A1 (fr)
AU476761B2 (fr)
AR201235Q (fr)
AR201231Q (fr)
AU474593B2 (fr)
AU474511B2 (fr)
AU474838B2 (fr)
AU450229B2 (fr)
AU476714B2 (fr)
AR201229Q (fr)
AU476696B2 (fr)
FR2227857B1 (fr)
AU7123074A (fr)
AU477823B2 (fr)
AU447540B2 (fr)
AR201432A1 (fr)
AU461342B2 (fr)
AR195948A1 (fr)
AU477824B2 (fr)
AR210729A1 (fr)
AU476873B1 (fr)
AR196212Q (fr)
AU1891376A (fr)
AU479521A (fr)
AU479496A (fr)

Legal Events

Date Code Title Description
ST Notification of lapse